Fingerprint
Dive into the research topics of 'Efficacy of the PARP inhibitor veliparib with carboplatin or as a single agent in patients with germline BRCA1- or BRCA2-associated metastatic breast cancer: California Cancer Consortium trial NCT01149083'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically